 Connection
Stanley Szefler to Placebos
This is a "connection" page, showing publications Stanley Szefler has written about Placebos.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.155 |
|
|
|
-
Papadopoulos NG, Szefler SJ, Bacharier LB, Maspero JF, Domingo C, Fiocchi A, Lee JK, Daizadeh N, Lederer DJ, Hardin M, Gall R, Djandji M, Siddiqui S, Jacob-Nara JA, Deniz Y, Rowe PJ. Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma. Allergy. 2023 08; 78(8):2157-2167.
Score: 0.053
-
Graham LM, Kerstjens HAM, Vogelberg C, Hamelmann E, Szefler SJ, Pisternick-Ruf W, Engel M, El Azzi G, Unseld A, Foggs MB. Safety of tiotropium Respimat? in black or African-American patients with symptomatic asthma. Respir Med. 2019 08; 155:58-60.
Score: 0.040
-
Szefler SJ, Boushey HA, Pearlman DS, Togias A, Liddle R, Furlong A, Shah T, Knobil K. Time to onset of effect of fluticasone propionate in patients with asthma. J Allergy Clin Immunol. 1999 May; 103(5 Pt 1):780-8.
Score: 0.040
-
Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, Lazarus SC, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med. 2007 Feb 01; 175(3):228-34.
Score: 0.017
-
Erzurum SC, Leff JA, Cochran JE, Ackerson LM, Szefler SJ, Martin RJ, Cott GR. Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. Ann Intern Med. 1991 Mar 01; 114(5):353-60.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|